5.15
-0.45
(-8.04%)
At close: January 10 at 5:15:24 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,381.00
-4,381.00
-4,368.00
-2,146.00
Investing Cash Flow
359.00
359.00
-388.00
-81.00
Financing Cash Flow
--
--
--
23,176.00
End Cash Position
12,171.00
12,171.00
16,193.00
20,949.00
Capital Expenditure
-175.00
-175.00
-597.00
-81.00
Issuance of Capital Stock
--
--
--
23,176.00
Issuance of Debt
--
--
--
225.00
Repayment of Debt
--
--
--
-225.00
Free Cash Flow
-4,556.00
-4,556.00
-4,965.00
-2,227.00
12/31/2021 - 7/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HVO.L hVIVO plc
18.10
-0.55%
HOOK HOOKIPA Pharma Inc.
2.1500
+15.59%
AVCT.L Avacta Group Plc
51.00
0.00%
SCLP.L Scancell Holdings plc
10.10
+3.59%
0QF.DE Moderna, Inc.
41.54
-1.11%
SBTX.L SkinBioTherapeutics plc
16.00
+1.59%
AGTX Agentix Corp.
0.1300
-27.78%
GBIO Generation Bio Co.
0.9255
+1.69%
VICO.ST Vicore Pharma Holding AB (publ)
9.53
-4.70%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%